About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Alfacell and GENESIS to Collaborate | Main | Pfizer's Australian Patent Covering Atorvastatin Upheld; Patent Covering Atorvastatin Calcium Salt Held Invalid »

December 20, 2006

MedImmune and Biowa Agree to License

    By Jason Derry --

Medimmune #1 MedImmune, Inc. and Biowa, Inc. have announced a licensing and collaboration deal relating to development and commercialization of therapies for inflammatory diseases.  In particular, the agreement relates to treatments that target interleukin-5 receptor.  The companies have indicated that the initial focus will be on a monoclonal antibody, BIW-8405, which is in Phase I clinical trials with asthma patients.  BIW-8405 is a humanized monoclonal antibody that binds to the IL-5 receptor.  Biowa has developed the antibody using its POTELLIGENT® technology.

Biowa Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 01:13 PM in Biotech/Pharma Business, Licensing |

Comments

The comments to this entry are closed.

January 2023

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31        

Categories

Archives

More...